GO:0015833 peptide transport: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0015833 peptide transport describes the directed movement of peptides across membranes or within cells by transporters or pores.
• Peptide transport is essential for nutrient uptake, cell signaling, and drug absorption in organisms from bacteria to humans.
• Key transporter families include the PTR family (proton-coupled oligopeptide transporters) such as PepT1 (SLC15A1) and PepT2 (SLC15A2).
• In bacteria, peptide transport supports nutrient scavenging and cell-wall recycling, with transporters like Dpp and Opp.
• In humans, intestinal PepT1 mediates absorption of di/tripeptides and peptidomimetic drugs, influencing drug bioavailability.
• Dysregulation of peptide transport is linked to metabolic disorders, cancer, and neurological diseases, making it a therapeutic target.
Description
Peptide transport (GO:0015833) is a fundamental biological process that mediates the movement of peptides, which are short chains of amino acids, across cellular membranes or between cellular compartments. This process is essential for nutrient acquisition, intercellular signaling, and the disposition of peptide-based drugs. In microorganisms, peptide transport systems allow the uptake of peptides as carbon and nitrogen sources, and play roles in quorum sensing and virulence. In plants, peptide transporters are involved in nitrogen allocation and long-distance signaling. In mammals, peptide transporters such as PepT1 and PepT2 are critical for the absorption of dietary peptides and peptidomimetic drugs in the intestine and kidney, and for neuropeptide clearance at the blood-cerebrospinal fluid barrier. Understanding the molecular mechanisms, regulation, and physiological roles of peptide transport is therefore of broad interest to researchers in microbiology, plant biology, pharmacology, and medicine.
peptide transport At A Glance
| GO ID | GO:0015833 |
|---|---|
| GO term | peptide transport |
| Ontology | biological_process |
| Synonym | none |
| Major function | Directed movement of peptides across membranes or within cells via transporters or pores |
| Key transporters | PTR family (PepT1/SLC15A1, PepT2/SLC15A2), ABC transporters (Opp, Dpp), and others |
| Cellular locations | Plasma membrane, intracellular vesicles, bacterial inner membrane, plant plasma membrane |
| Associated diseases | Metabolic disorders, cancer, neurological diseases, drug absorption variability |
| Research methods | Transport assays, electrophysiology, CRISPR knockout, structural biology, proteomics |
What Is GO:0015833?
According to the Gene Ontology, peptide transport (GO:0015833) is defined as the directed movement of peptides, compounds of two or more amino acids where the alpha carboxyl group of one is bound to the alpha amino group of another, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. This process encompasses the translocation of peptides across biological membranes, typically mediated by specialized membrane proteins that recognize and transport peptides, often coupled to ion gradients or ATP hydrolysis.
Why Is peptide transport Important in Cell Biology?
Peptide transport is crucial for fundamental cellular processes such as nutrient uptake, cell-cell communication, and drug delivery. In microorganisms, it enables the scavenging of peptides as nutrients and contributes to pathogenesis. In plants, it facilitates nitrogen distribution and signaling. In humans, intestinal peptide transport by PepT1 is a major route for the absorption of dietary amino acids and peptidomimetic drugs, affecting drug efficacy and safety. Moreover, peptide transporters at the blood-cerebrospinal fluid barrier regulate neuropeptide levels, impacting brain function. Dysregulation of peptide transport has been implicated in various diseases, including inflammatory bowel disease, cancer, and neurodegenerative disorders, highlighting its clinical importance.
• Enables nutrient uptake from peptides in bacteria, plants, and animals.
• Mediates intestinal absorption of di/tripeptides and peptidomimetic drugs, influencing drug bioavailability.
• Regulates neuropeptide homeostasis at the blood-CSF barrier, affecting brain physiology.
• Contributes to bacterial virulence and quorum sensing through peptide uptake.
• Plays a role in plant nitrogen allocation and long-distance signaling.
• Involved in renal reabsorption of peptides, impacting fluid and electrolyte balance.
• Target for prodrug design to improve oral absorption of poorly permeable drugs.
• Dysregulation linked to cancer cell metabolism and proliferation.
• Potential biomarker for drug response and disease states.
• Provides a model system for studying proton-coupled transport mechanisms.
What Happens During peptide transport?
Substrate Recognition and Binding
In simple terms: The transporter first grabs the peptide it will carry across the membrane.
Peptide transporters recognize their substrates through specific binding pockets that accommodate peptides of varying lengths and sequences. For example, the PTR family transporters, such as PepT1, bind di- and tripeptides with broad specificity, allowing transport of diverse peptide sequences and peptidomimetic drugs. In bacteria, ABC transporters like Opp bind peptides via periplasmic binding proteins before translocation. This initial recognition step is critical for selectivity and is often coupled to conformational changes in the transporter.
Translocation Across the Membrane
In simple terms: The transporter undergoes shape changes to move the peptide through the membrane.
After binding, the transporter undergoes conformational changes that move the peptide across the lipid bilayer. Proton-coupled transporters, such as those in the PTR family, utilize the electrochemical proton gradient to drive peptide uptake. In contrast, ABC transporters use ATP hydrolysis to power peptide transport. The alternating access mechanism is a common theme, where the transporter switches between outward-facing and inward-facing states to release the substrate on the other side.
Energy Coupling and Driving Forces
In simple terms: The cell uses energy, often from protons or ATP, to push peptides across the membrane.
Peptide transport is energized by various sources. In the intestine, PepT1 is driven by a transmembrane proton gradient, where the inward movement of protons is coupled to peptide uptake. This proton-coupled mechanism is a hallmark of the PTR family. In bacteria, ABC transporters like Opp and Dpp utilize ATP-binding cassettes to energize peptide import. The energy coupling ensures transport against concentration gradients, allowing cells to accumulate peptides.
Release and Intracellular Processing
In simple terms: Once inside, the peptide is released and often broken down into amino acids.
Following translocation, the peptide is released into the cytoplasm or intracellular compartment. In bacteria, imported peptides are often degraded by peptidases to provide amino acids for metabolism. In mammalian cells, peptides transported by PepT1 are hydrolyzed by cytosolic peptidases, and the resulting amino acids enter metabolic pools. This release step is essential for maintaining cellular peptide homeostasis and preventing accumulation of transport substrates.
Regulation and Adaptation
In simple terms: Cells can adjust how many transporters they make based on need.
Peptide transport activity is regulated at multiple levels, including transcriptional control, post-translational modifications, and membrane trafficking. For instance, PepT1 expression in the intestine is influenced by dietary protein content and hormones. In bacteria, peptide transporter genes are often regulated by nutrient availability and quorum sensing signals. Such regulation allows organisms to adapt to changing environments and metabolic demands.
Key Genes Involved in GO:0015833 peptide transport
The following genes encode key transporters and regulators involved in peptide transport across various organisms.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC15A1 (PepT1) | Intestinal proton-coupled di/tripeptide transporter | Drug absorption, nutrient uptake, inflammatory bowel disease |
| SLC15A2 (PepT2) | Kidney and brain proton-coupled peptide transporter | Renal peptide reabsorption, neuropeptide clearance |
| SLC15A3 (PHT2) | Lysosomal peptide/histidine transporter | Immune function, antigen presentation |
| SLC15A4 (PHT1) | Endolysosomal peptide/histidine transporter | Autoimmune diseases, TLR signaling |
| SLC15A5 | Orphan peptide transporter | Poorly characterized, potential metabolic roles |
| PTR1 | Plant proton-coupled peptide transporter | Nitrogen allocation, signaling |
| PTR2 | Plant peptide transporter | Seed development, stress response |
| OppA | Bacterial periplasmic peptide-binding protein | Nutrient scavenging, virulence |
| OppB | Bacterial ABC transporter permease | Peptide uptake, cell wall recycling |
| OppC | Bacterial ABC transporter permease | Peptide uptake, cell wall recycling |
| OppD | Bacterial ABC transporter ATPase | Energy coupling for peptide transport |
| OppF | Bacterial ABC transporter ATPase | Energy coupling for peptide transport |
| DppA | Bacterial dipeptide-binding protein | Dipeptide uptake, sporulation |
| DppB | Bacterial dipeptide permease | Dipeptide uptake |
| DppC | Bacterial dipeptide permease | Dipeptide uptake |
| DppD | Bacterial dipeptide ATPase | Energy coupling for dipeptide transport |
| DppF | Bacterial dipeptide ATPase | Energy coupling for dipeptide transport |
How Is peptide transport Regulated?
Peptide transport is regulated at transcriptional, post-transcriptional, and post-translational levels. In mammals, PepT1 (SLC15A1) expression is induced by dietary protein and hormones such as insulin and leptin, and is downregulated during inflammation. In bacteria, peptide transporter genes are controlled by nutrient-sensing regulators and quorum-sensing systems. In plants, peptide transporter expression responds to nitrogen status and developmental cues. Additionally, membrane trafficking and phosphorylation can modulate transporter activity.
peptide transport and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC15A1 (PepT1) | Inflammatory bowel disease, drug absorption variability | Intestinal epithelial cell knockout (Caco-2) |
| SLC15A2 (PepT2) | Neurodegeneration, renal dysfunction | Kidney or brain cell knockout (HEK293) |
| SLC15A4 (PHT1) | Autoimmune diseases (lupus, colitis) | Immune cell knockout (macrophages) |
| OppA | Bacterial virulence | Bacterial knockout (Salmonella, E. coli) |
| PTR1 | Plant nitrogen use efficiency | Arabidopsis knockout |
Peptide Transport in Cancer
Altered peptide transport contributes to cancer metabolism and drug resistance. PepT1 (SLC15A1) is overexpressed in some cancers, enhancing the uptake of peptidomimetic drugs and potentially affecting chemotherapy efficacy. Targeting peptide transporters may improve drug delivery and overcome resistance.
Peptide Transport and Neurological Disorders
At the blood-cerebrospinal fluid barrier, peptide transporters such as PepT2 (SLC15A2) regulate neuropeptide levels. Dysfunction of these transporters has been implicated in neurodegenerative diseases and neuroinflammation. Understanding their role may lead to new therapies for brain disorders.
Peptide Transport in Infectious Diseases
Bacterial peptide transporters are essential for nutrient acquisition and virulence. Inhibiting peptide uptake could be a strategy to combat bacterial infections. For example, Opp and Dpp systems are required for full virulence in some pathogens.
From peptide transport-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does SLC15A1 mediate drug uptake? | SLC15A1 knockout in Caco-2 cells |
| What is the role of SLC15A2 in neuropeptide clearance? | SLC15A2 knockout in brain endothelial cells |
| How does SLC15A4 affect immune signaling? | SLC15A4 point mutation in macrophages |
| Can bacterial Opp system be targeted for antibiotics? | OppA knockout in Salmonella |
| Does PTR1 regulate nitrogen allocation? | PTR1 overexpression in Arabidopsis |
| What is the effect of PepT1 tagging on localization? | Knock-in of fluorescent tag in SLC15A1 |
How to Study the peptide transport Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radiolabeled peptide uptake | Transport rate and kinetics | Characterizing PepT1 substrates |
| Electrophysiology | Proton currents and transport stoichiometry | Mechanistic studies of PTR family |
| Cryo-EM | 3D structure of transporter | Understanding conformational states |
| CRISPR knockout | Gene function in transport | Identifying regulators of peptide uptake |
| RNA-seq | Expression of transporters | Tissue-specific expression profiling |
| Proteomics | Protein abundance and interactions | Identifying transporter complexes |
| Fluorescent peptide imaging | Subcellular localization and transport | Live-cell tracking of peptide movement |
Transport Assays
Radiolabeled or fluorescently labeled peptides are used to measure uptake in cells or membrane vesicles. These assays quantify transport kinetics and substrate specificity.
Electrophysiology
Two-electrode voltage clamp or patch clamp on Xenopus oocytes expressing transporters measures proton-coupled currents, revealing stoichiometry and voltage dependence.
Structural Biology
Cryo-EM and X-ray crystallography provide atomic structures of peptide transporters, elucidating binding pockets and conformational changes.
CRISPR Screening
Genome-wide CRISPR knockout screens identify genes that regulate peptide transport activity or drug sensitivity.
How CRISPR Can Be Used to Study GO:0015833 peptide transport
Knockout
CRISPR knockout of peptide transporter genes (e.g., SLC15A1, SLC15A2) in cell lines or animal models ablates transport activity, allowing researchers to study loss-of-function phenotypes such as reduced drug uptake or altered nutrient sensing.
Point Mutation
Introducing point mutations in transporter genes can mimic human polymorphisms or disrupt key residues, enabling structure-function studies and personalized drug response modeling.
Knock-in
Knock-in of epitope tags or fluorescent proteins into endogenous transporter loci allows real-time tracking of localization and dynamics without overexpression artifacts.
Overexpression
CRISPR activation or cDNA overexpression of peptide transporters increases transport capacity, useful for drug screening and structural studies.
How EDITGENE Supports peptide transport Research
Researchers studying peptide transport-related genes often need to determine whether a candidate gene is causally involved in transport, how mutations affect function, and where the protein localizes. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for peptide transport research.
Frequently Asked Questions About peptide transport
What is peptide transport (GO:0015833)?
Peptide transport is the directed movement of peptides across membranes or within cells by transporters or pores, as defined by the Gene Ontology.
What genes are involved in peptide transport?
Key genes include SLC15A1 (PepT1), SLC15A2 (PepT2), SLC15A4 (PHT1), and bacterial opp and dpp operons.
How does PepT1 transport peptides?
PepT1 is a proton-coupled transporter that uses the proton gradient to drive di/tripeptide uptake across the intestinal brush border.
What diseases are linked to peptide transport?
Peptide transport dysregulation is associated with inflammatory bowel disease, cancer, neurological disorders, and autoimmune diseases.
What methods are used to study peptide transport?
Common methods include radiolabeled uptake assays, electrophysiology, cryo-EM, and CRISPR knockout models.
Can peptide transporters be targeted for drug delivery?
Yes, PepT1 is exploited for oral absorption of peptidomimetic prodrugs, improving bioavailability.
What is the role of peptide transport in bacteria?
Bacterial peptide transporters like Opp and Dpp scavenge peptides for nutrients and contribute to virulence.
How is peptide transport regulated?
Regulation occurs via nutrient availability, hormones, and transcriptional factors, affecting transporter expression and activity.
What is the blood-CSF barrier peptide transport?
Transporters at the blood-CSF barrier regulate neuropeptide levels, impacting brain function.
How can CRISPR help study peptide transport?
CRISPR knockout, knock-in, and point mutation models enable precise functional studies of peptide transporters in cells and animals.
Conclusion
Peptide transport (GO:0015833) is a vital biological process with broad implications in nutrition, drug delivery, and disease. Understanding its molecular mechanisms and regulation offers opportunities for therapeutic intervention. EDITGENE provides advanced CRISPR tools to dissect peptide transport pathways and accelerate discovery.
References
- 1. Stacey G et al.. 2002. Peptide transport in plants.. Trends Plant Sci 7(6):257-63 PMID: 12049922
- 2. Payne JW et al.. 1994. Peptide transport by micro-organisms.. Adv Microb Physiol 36:1-80 PMID: 7942312
- 3. Brodin B et al.. 2002. Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1.. Pharmacol Toxicol 90(6):285-96 PMID: 12403049
- 4. Newstead S. 2015. Molecular insights into proton coupled peptide transport in the PTR family of oligopeptide transporters.. Biochim Biophys Acta 1850(3):488-99 PMID: 24859687
- 5. Sussman AJ et al.. 1971. Peptide transport and metabolism in bacteria.. Annu Rev Biochem 40:397-408 PMID: 5001044
- 6. Daniel H. 2004. Molecular and integrative physiology of intestinal peptide transport.. Annu Rev Physiol 66:361-84 PMID: 14977407
- 7. Ganapathy et al.. 1985. Is intestinal peptide transport energized by a proton gradient?. Am J Physiol 249(2 Pt 1):G153-60 PMID: 2992286
- 8. Smith DE et al.. 2004. Peptide and peptide analog transport systems at the blood-CSF barrier.. Adv Drug Deliv Rev 56(12):1765-91 PMID: 15381333
